SCHEMBL6784264

SCHEMBL6784264

O=C/C(=C/Cc1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.49
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ESR1 P03372 3/20 0.38
▸ ESR2 Q92731 3/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CA2 P00918 3/20 0.36
▸ CAMK2A Q9UQM7 1/20 0.36
▸ ABAT P80404 3/20 0.35
▸ ALDH5A1 P51649 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ TYR P14679 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784267 1.00 NQO2 (0.49) NQO2MEN1KMT2AESR1ESR2
SCHEMBL27833892 0.92 NPC1 (0.50) NQO2MEN1KMT2AESR1ESR2
SCHEMBL28264296 0.92 ABAT (0.52) NQO2MEN1KMT2ALMNACA2
SCHEMBL27762421 0.92 NPC1 (0.50) NQO2MEN1KMT2AESR1ESR2
SCHEMBL28263236 0.91 LMNA (0.45) NQO2MEN1KMT2AESR1ESR2
SCHEMBL27565138 0.91 FNTA (0.42) NQO2MEN1KMT2AESR1ESR2
SCHEMBL28263238 0.87 MAPT (0.49) NQO2MEN1KMT2AESR2NPC1
SCHEMBL28271291 0.87 ESR1 (0.44) NQO2MEN1KMT2AESR1ESR2
SCHEMBL11870822 0.83 SRD5A2 (0.40) NQO2MEN1KMT2ANPC1RAB9A
SCHEMBL11870828 0.83 SRD5A2 (0.40) NQO2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-10918609-B2 Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2021-02-16 — — US disclosed
WO-2020206424-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed
US-20190175521-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS OR INFLAMMATORY DISEASE CONTAINING 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROPYL-1-EN-1-YL)PHENOL AS ACTIVE INGREDIENT CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2019-06-13 — — US disclosed
US-10265276-B2 Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2019-04-23 — — US disclosed
US-10125073-B2 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol and preparation method therefor CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2018-11-13 — — US disclosed
US-20180133169-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS OR INFLAMMATORY DISEASE CONTAINING 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROPYL-1-EN-1-YL)PHENOL AS ACTIVE INGREDIENT Chungbuk National University Industry-Academic Coo peration Foundation (KR) 2018-05-17 — — US disclosed
US-20180044275-A1 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROP-1-EN-1-YL)PHENOL AND PREPARATION METHOD THEREFOR CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2018-02-15 — — US disclosed
CN-107438433-A Pharmaceutical composition for preventing and treating arthritis or inflammatory diseases containing 2-methoxy-4- (3- (4-methoxyphenyl) prop-1-en-1-yl) phenol as an active ingredient 忠北大学校产学协力团 2017-12-05 — — CN disclosed
CN-107428647-A 2 methoxyl groups 4 (3 (4 methoxyphenyls) the third 1 base of alkene 1) phenol and preparation method thereof 忠北大学校产学协力团 2017-12-01 — — CN disclosed
WO-2016144042-A1 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROP-1-EN-1-YL)PHENOL AND PREPARATION METHOD THEREFOR 충북대학교 산학협력단 2016-09-15 — — WO disclosed
US-6803367-B2 ANTICANCER AGENTS; SYNERGISTIC MIXTURES TAKARA SHUZO CO., LTD. (JP) 2004-10-12 — — US disclosed
US-20030065014-A1 Substance for inducing apoptosis TAKARA BIO INC. (JP) 2003-04-03 — — US disclosed
US-6525082-B1 2-hydroxy-4-(1-imidazolyl)-2-cyclopenten-1-one; inhibiting growth of cancer cells TAKARA SHUZO CO., LTD. (JP) 2003-02-25 — — US disclosed
EP-1048641-A1 APOPTOSIS INDUCER Takara Shuzo Co, Ltd. (JP) 2000-11-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044275-A1 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROP-1-EN-1-YL)PHENOL AND PREPARATION METHOD THEREFOR STAT3, RELA, NFKBIA NQO2 2908/4885MEN1 2277/4885KMT2A 1404/4885
US-20030065014-A1 Substance for inducing apoptosis BAX, BCL2, BAD NQO2 2200/4885MEN1 3606/4885KMT2A 4360/4885
US-20180133169-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS OR INFLAMMATORY DISEASE CONTAINING 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROPYL-1-EN-1-YL)PHENOL AS ACTIVE INGREDIENT TYR, COL2A1, SYVN1 NQO2 3091/4885MEN1 2907/4885KMT2A 1344/4885
US-20190175521-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ARTHRITIS OR INFLAMMATORY DISEASE CONTAINING 2-METHOXY-4-(3-(4-METHOXYPHENYL)PROPYL-1-EN-1-YL)PHENOL AS ACTIVE INGREDIENT TYR, COL2A1, SYVN1 NQO2 3091/4885MEN1 2907/4885KMT2A 1344/4885
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 NQO2 1158/4885MEN1 3280/4885KMT2A 737/4885
US-10918609-B2 Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient TYR, COL2A1, SYVN1 NQO2 3091/4885MEN1 2907/4885KMT2A 1344/4885
US-10125073-B2 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol and preparation method therefor STAT3, RELA, NFKBIA NQO2 2908/4885MEN1 2277/4885KMT2A 1404/4885
US-10265276-B2 Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient TYR, COL2A1, SYVN1 NQO2 3091/4885MEN1 2907/4885KMT2A 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback